HSP90 inhibitors target KRAS mutant human tumors through degradation of STK33 Meeting Abstract


Authors: Azoitei, N.; Hoffmann, C. M.; Ellegast, J. M.; Ball, C. R.; Obermayer, K.; Gossele, U.; Koch, B.; Faber, K.; Genze, F.; Schrader, M.; Kestler, H. A.; Dohner, H.; Chiosis, G.; Glimm, H.; Frohling, S.; Scholl, C.
Abstract Title: HSP90 inhibitors target KRAS mutant human tumors through degradation of STK33
Meeting Title: 103rd Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 72
Issue: 8 Suppl.
Meeting Dates: 2012 Mar 31-Apr 4
Meeting Location: Chicago, IL
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2012-04-01
Language: English
ACCESSION: WOS:000209701603253
DOI: 10.1158/1538-7445.am2012-2773
PROVIDER: wos
Notes: Meeting Abstract: 2773 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gabriela Chiosis
    281 Chiosis